Quote:
Originally Posted by CrimsonFox
what bad publicity
|
You can always count on Bernie.
I agree with Bernie on this one. I don’t know how much the US really subsidized all expenses (100% or 60% or ?) and they may have been able to profit more using those resources selling other stuff (e.g. the opportunity cost).
But Moderna is probably much ahead on the overall ‘balance sheet’ with all the good publicity, stock appreciation, acceptance of mRNA, leveraging lessons learn from their development of the vaccine etc.
Go sic ‘em Bernie.
https://www.cnbc.com/2023/02/15/mode...rice-hike.html
Quote:
Moderna CEO Stéphane Bancel will testify before the Senate health committee in March over the company’s price for its Covid-19 vaccine when the shots are sold on the private market.
Sen. Bernie Sanders, chairman of the health panel, confirmed in a statement on Wednesday that Bancel would appear at a hearing titled: “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?”
Bancel will testify at 10 a.m. ET on March 22.
The Moderna CEO stirred controversy last month when he said the company could increase the price of the shots to $110 to $130 a dose, significantly higher than the $26 the U.S. government pays for the omicron boosters. Sanders sent a letter to the CEO calling the proposed price hike “outrageous.”
Moderna, in a statement Wednesday, said it will provide the vaccines to the uninsured at no cost through a patient assistance program.
“For uninsured or underinsured people, Moderna’s patient assistance program will provide COVID-19 vaccines at no cost,” the company said.
Sanders, in a letter to Bancel last month, slammed the proposed price hike as “outrageous” because the vaccine was developed in cooperation with the National Institutes of Health using taxpayer money.
|